Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q408155> ?p ?o }
Showing triples 1 to 49 of
49
with 100 triples per page.
- Q408155 subject Q6809004.
- Q408155 abstract "Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma (Germany).".
- Q408155 atcPrefix "L01".
- Q408155 atcSuffix "XC09".
- Q408155 casNumber "509077-98-9".
- Q408155 wikiPageExternalLink www.removab.com.
- Q408155 wikiPageWikiLink Q1030169.
- Q408155 wikiPageWikiLink Q1047791.
- Q408155 wikiPageWikiLink Q130146.
- Q408155 wikiPageWikiLink Q1400536.
- Q408155 wikiPageWikiLink Q1483951.
- Q408155 wikiPageWikiLink Q173235.
- Q408155 wikiPageWikiLink Q18028744.
- Q408155 wikiPageWikiLink Q181876.
- Q408155 wikiPageWikiLink Q183.
- Q408155 wikiPageWikiLink Q184204.
- Q408155 wikiPageWikiLink Q186889.
- Q408155 wikiPageWikiLink Q188724.
- Q408155 wikiPageWikiLink Q193529.
- Q408155 wikiPageWikiLink Q193889.
- Q408155 wikiPageWikiLink Q212354.
- Q408155 wikiPageWikiLink Q30.
- Q408155 wikiPageWikiLink Q30612.
- Q408155 wikiPageWikiLink Q332181.
- Q408155 wikiPageWikiLink Q36396.
- Q408155 wikiPageWikiLink Q3776943.
- Q408155 wikiPageWikiLink Q39275.
- Q408155 wikiPageWikiLink Q417823.
- Q408155 wikiPageWikiLink Q419458.
- Q408155 wikiPageWikiLink Q422248.
- Q408155 wikiPageWikiLink Q46.
- Q408155 wikiPageWikiLink Q506253.
- Q408155 wikiPageWikiLink Q582687.
- Q408155 wikiPageWikiLink Q6809004.
- Q408155 wikiPageWikiLink Q705361.
- Q408155 wikiPageWikiLink Q7841565.
- Q408155 wikiPageWikiLink Q878592.
- Q408155 wikiPageWikiLink Q949267.
- Q408155 wikiPageWikiLink Q9629.
- Q408155 atcPrefix "L01".
- Q408155 atcSuffix "XC09".
- Q408155 casNumber "509077".
- Q408155 type ChemicalSubstance.
- Q408155 type Drug.
- Q408155 type ChemicalObject.
- Q408155 type Thing.
- Q408155 type Q8386.
- Q408155 comment "Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma (Germany).".
- Q408155 label "Catumaxomab".